annual CAPEX:
$19.99M-$26.78M(-57.25%)Summary
- As of today (September 16, 2025), RARE annual capital expenditures is $19.99 million, with the most recent change of -$26.78 million (-57.25%) on December 31, 2024.
- During the last 3 years, RARE annual CAPEX has fallen by -$53.10 million (-72.65%).
- RARE annual CAPEX is now -86.32% below its all-time high of $146.12 million, reached on December 31, 2022.
Performance
RARE CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CAPEX:
$2.46M-$13.86M(-84.93%)Summary
- As of today (September 16, 2025), RARE quarterly capital expenditures is $2.46 million, with the most recent change of -$13.86 million (-84.93%) on June 30, 2025.
- Over the past year, RARE quarterly CAPEX has dropped by -$2.05 million (-45.44%).
- RARE quarterly CAPEX is now -96.04% below its all-time high of $62.18 million, reached on March 31, 2022.
Performance
RARE quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CAPEX:
$21.05M-$2.05M(-8.87%)Summary
- As of today (September 16, 2025), RARE TTM capital expenditures is $21.05 million, with the most recent change of -$2.05 million (-8.87%) on June 30, 2025.
- Over the past year, RARE TTM CAPEX has dropped by -$1.96 million (-8.52%).
- RARE TTM CAPEX is now -85.59% below its all-time high of $146.12 million, reached on December 31, 2022.
Performance
RARE TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
RARE CAPEX Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -57.3% | -45.4% | -8.5% |
| 3 y3 years | -72.7% | -92.0% | -83.8% |
| 5 y5 years | -19.5% | -39.8% | -39.3% |
RARE CAPEX Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -86.3% | at low | -92.0% | +276.1% | -85.6% | +5.3% |
| 5 y | 5-year | -86.3% | at low | -96.0% | +276.1% | -85.6% | +5.3% |
| alltime | all time | -86.3% | +4811.8% | -96.0% | +2511.8% | -85.6% | >+9999.0% |
RARE CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $2.46M(-84.9%) | $21.05M(-8.9%) |
| Mar 2025 | - | $16.32M(+2396.0%) | $23.10M(+15.6%) |
| Dec 2024 | $19.99M(-57.3%) | $654.00K(-59.6%) | $19.99M(-4.5%) |
| Sep 2024 | - | $1.62M(-64.1%) | $20.94M(-9.0%) |
| Jun 2024 | - | $4.51M(-65.9%) | $23.02M(-34.1%) |
| Mar 2024 | - | $13.21M(+725.7%) | $34.94M(-25.3%) |
| Dec 2023 | $46.77M(-68.0%) | $1.60M(-56.7%) | $46.77M(-35.2%) |
| Sep 2023 | - | $3.69M(-77.5%) | $72.14M(-23.7%) |
| Jun 2023 | - | $16.44M(-34.3%) | $94.49M(-13.3%) |
| Mar 2023 | - | $25.03M(-7.2%) | $108.97M(-25.4%) |
| Dec 2022 | $146.12M(+99.9%) | $26.97M(+3.5%) | $146.12M(+8.1%) |
| Sep 2022 | - | $26.05M(-15.8%) | $135.20M(+4.2%) |
| Jun 2022 | - | $30.92M(-50.3%) | $129.72M(+9.1%) |
| Mar 2022 | - | $62.18M(+287.5%) | $118.86M(+62.6%) |
| Dec 2021 | $73.09M(+66.5%) | $16.05M(-21.9%) | $73.09M(-4.7%) |
| Sep 2021 | - | $20.56M(+2.4%) | $76.72M(+23.3%) |
| Jun 2021 | - | $20.07M(+22.3%) | $62.21M(+34.6%) |
| Mar 2021 | - | $16.41M(-16.6%) | $46.22M(+5.3%) |
| Dec 2020 | $43.91M(+76.8%) | $19.67M(+224.9%) | $43.91M(+22.9%) |
| Sep 2020 | - | $6.05M(+48.3%) | $35.73M(+2.9%) |
| Jun 2020 | - | $4.08M(-71.0%) | $34.71M(-3.2%) |
| Mar 2020 | - | $14.10M(+22.6%) | $35.87M(+44.4%) |
| Dec 2019 | $24.83M(+509.2%) | $11.50M(+128.5%) | $24.83M(+71.0%) |
| Sep 2019 | - | $5.03M(-4.0%) | $14.52M(+38.0%) |
| Jun 2019 | - | $5.24M(+71.3%) | $10.52M(+58.0%) |
| Mar 2019 | - | $3.06M(+156.6%) | $6.66M(+63.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2018 | $4.08M(+45.9%) | $1.19M(+15.5%) | $4.08M(+7.7%) |
| Sep 2018 | - | $1.03M(-25.1%) | $3.78M(-0.0%) |
| Jun 2018 | - | $1.38M(+189.9%) | $3.78M(+36.0%) |
| Mar 2018 | - | $475.00K(-47.2%) | $2.78M(-0.4%) |
| Dec 2017 | $2.79M(-72.6%) | $899.00K(-13.0%) | $2.79M(+9.1%) |
| Sep 2017 | - | $1.03M(+174.7%) | $2.56M(-43.5%) |
| Jun 2017 | - | $376.00K(-22.5%) | $4.53M(-50.8%) |
| Mar 2017 | - | $485.00K(-27.2%) | $9.20M(-9.7%) |
| Dec 2016 | $10.19M(+105.6%) | $666.00K(-77.8%) | $10.19M(-11.0%) |
| Sep 2016 | - | $3.00M(-40.5%) | $11.45M(+9.8%) |
| Jun 2016 | - | $5.04M(+241.5%) | $10.42M(+74.5%) |
| Mar 2016 | - | $1.48M(-23.2%) | $5.97M(+20.5%) |
| Dec 2015 | $4.96M(+130.6%) | $1.92M(-2.8%) | $4.96M(+42.2%) |
| Sep 2015 | - | $1.98M(+232.4%) | $3.48M(+79.1%) |
| Jun 2015 | - | $595.00K(+29.6%) | $1.95M(-4.6%) |
| Mar 2015 | - | $459.00K(+1.3%) | $2.04M(-5.1%) |
| Dec 2014 | $2.15M(+428.0%) | $453.00K(+3.2%) | $2.15M(+17.8%) |
| Sep 2014 | - | $439.00K(-36.2%) | $1.82M(+14.9%) |
| Jun 2014 | - | $688.00K(+20.9%) | $1.59M(+98.9%) |
| Mar 2014 | - | $569.00K(+341.1%) | $799.00K(+96.3%) |
| Dec 2013 | $407.00K(-62.7%) | $129.00K(-36.5%) | $407.00K(+1.2%) |
| Sep 2013 | - | $203.00K(-299.0%) | $402.00K(+81.9%) |
| Jun 2013 | - | -$102.00K(-157.6%) | $221.00K(-31.6%) |
| Mar 2013 | - | $177.00K(+42.7%) | $323.00K(+121.2%) |
| Dec 2012 | $1.09M(+99.1%) | $124.00K(+463.6%) | $146.00K(+563.6%) |
| Sep 2012 | - | $22.00K | $22.00K |
| Dec 2011 | $548.00K | - | - |
FAQ
- What is Ultragenyx Pharmaceutical Inc. annual capital expenditures?
- What is the all time high annual CAPEX for Ultragenyx Pharmaceutical Inc.?
- What is Ultragenyx Pharmaceutical Inc. annual CAPEX year-on-year change?
- What is Ultragenyx Pharmaceutical Inc. quarterly capital expenditures?
- What is the all time high quarterly CAPEX for Ultragenyx Pharmaceutical Inc.?
- What is Ultragenyx Pharmaceutical Inc. quarterly CAPEX year-on-year change?
- What is Ultragenyx Pharmaceutical Inc. TTM capital expenditures?
- What is the all time high TTM CAPEX for Ultragenyx Pharmaceutical Inc.?
- What is Ultragenyx Pharmaceutical Inc. TTM CAPEX year-on-year change?
What is Ultragenyx Pharmaceutical Inc. annual capital expenditures?
The current annual CAPEX of RARE is $19.99M
What is the all time high annual CAPEX for Ultragenyx Pharmaceutical Inc.?
Ultragenyx Pharmaceutical Inc. all-time high annual capital expenditures is $146.12M
What is Ultragenyx Pharmaceutical Inc. annual CAPEX year-on-year change?
Over the past year, RARE annual capital expenditures has changed by -$26.78M (-57.25%)
What is Ultragenyx Pharmaceutical Inc. quarterly capital expenditures?
The current quarterly CAPEX of RARE is $2.46M
What is the all time high quarterly CAPEX for Ultragenyx Pharmaceutical Inc.?
Ultragenyx Pharmaceutical Inc. all-time high quarterly capital expenditures is $62.18M
What is Ultragenyx Pharmaceutical Inc. quarterly CAPEX year-on-year change?
Over the past year, RARE quarterly capital expenditures has changed by -$2.05M (-45.44%)
What is Ultragenyx Pharmaceutical Inc. TTM capital expenditures?
The current TTM CAPEX of RARE is $21.05M
What is the all time high TTM CAPEX for Ultragenyx Pharmaceutical Inc.?
Ultragenyx Pharmaceutical Inc. all-time high TTM capital expenditures is $146.12M
What is Ultragenyx Pharmaceutical Inc. TTM CAPEX year-on-year change?
Over the past year, RARE TTM capital expenditures has changed by -$1.96M (-8.52%)